Survodutide (10 mg Vial)
Complete dosage protocol and reconstitution guide for Survodutide (10 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.
CAT No:
CAS No:
Synonyms/Alias:Survodutide
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Complete dosage protocol and reconstitution guide for Survodutide (10 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.
Quickstart
Reconstitute: Add 2.0 mL bacteriostatic water → 5 mg/mL (5000 mcg/mL) concentration.
Typical weekly range: 0.6–6.0 mg once weekly (gradual titration over 10–12 weeks).
Easy measuring: At 5 mg/mL, 1 unit = 0.01 mL = 50 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at ≤−20 °C (≤−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; protect from light.
Notes
Practical considerations for consistency and safety. Use new sterile syringes; dispose in a sharps container. Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation. Inject slowly; wait a few seconds before withdrawing the needle. Document weekly dose, injection site, and any tolerability observations. For doses exceeding 100 units (1.0 mL), consider using a 1 mL Luer‑lock syringe or splitting into two injections.
Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.
Peptide Vials (Survodutide, 10 mg each): 8 weeks ≈ 2 vials (~17 mg total)
12 weeks ≈ 4 vials (~39 mg total)
16 weeks ≈ 7 vials (~63 mg total)
Insulin Syringes (U‑100) or 1 mL Luer‑lock Syringes: Per week: 1 syringe (once weekly)
8 weeks: 8 syringes
12 weeks: 12 syringes
16 weeks: 16 syringes
Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution. 8 weeks (2 vials): 4 mL → 1 × 10 mL bottle
12 weeks (4 vials): 8 mL → 1 × 10 mL bottle
16 weeks (7 vials): 14 mL → 2 × 10 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each week. Per week: 2 swabs
8 weeks: 16 swabs
12 weeks: 24 swabs
16 weeks: 32 swabs → recommend 1 × 100‑count box
Goal: Support metabolic improvement and weight management through dual GLP‑1/glucagon receptor activation [1] [3] .
Schedule: Weekly subcutaneous injections for 12–16 weeks (or longer as studied in phase 3 trials).
Dose Range: 0.6–6.0 mg weekly with gradual titration over 10–12 weeks.
Reconstitution: 2.0 mL per 10 mg vial (5 mg/mL) for accurate unit measurements.
Storage: Lyophilized frozen; reconstituted refrigerated; protect from light and avoid freeze–thaw.
Start: 0.6 mg weekly; increase by 0.6 mg every 2 weeks as tolerated.
Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.
Email: kongq687@gmail.com
Address: Huangpu District, Guangzhou, China